Catalyst Wire Dossier Catalyst Wire Dossier

Hepavax-Gene TF

· Crucell Holland BV
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hepavax-Gene TF, covering 2014-03-04 to 2014-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns [Phase 3]

See pricing